TG Therapeutics(DE:NKB2)
€56.60-1.60 (-2.75%)
DE:NKB2
TG Therapeutics earnings date
€56.60
At close:-1.60 (-2.75%)
TG Therapeutics (NKB2) Q2 2026 Earnings Report
3 Followers
DE:NKB2 Q2 2026 EPS Results
- Actual EPS
- EUR 0.04
- Consensus EPS
- EUR 0.27
- Beat/Miss
- Missed by -EUR 0.23
- One Year Ago EPS
- EUR 0.15
DE:NKB2 Q2 2026 Revenue Results
- Actual Revenue
- EUR 215.18M
- Expected Revenue
- EUR 205.73M
- Beat/Miss
- Beat by +EUR 9.46M
- YoY Revenue Growth
- +70.27%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/03/2026
- Time
- Before Open
- Conference Call
- Monday, August 3, 2026
DE:NKB2 Upcoming Earnings
TG Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:NKB2 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NKB2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 0.47- | 0.13 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | 0.320.31 | 2.18 | -85.60% (-1.86) | |
| Aug 03, 2026 | 2026 (Q2) | 0.270.04 | 0.15 | -70.59% (-0.11) | |
| May 06, 2026 | 2026 (Q1) | 0.250.11 | 0.03 | 300.00% (+0.08) | |
| Feb 26, 2026 | 2025 (Q4) | 0.320.13 | 0.13 | -6.67% (-0.01) | |
| Nov 03, 2025 | 2025 (Q3) | 0.202.18 | 0.02 | 12050.00% (+2.16) | |
| Aug 04, 2025 | 2025 (Q2) | 0.190.15 | 0.04 | 325.00% (+0.12) | |
| May 05, 2025 | 2025 (Q1) | 0.150.03 | -0.06 | 142.86% (+0.09) | |
| Mar 03, 2025 | 2024 (Q4) | 0.140.13 | -0.08 | 266.67% (+0.21) | |
| Nov 04, 2024 | 2024 (Q3) | 0.030.02 | 0.65 | -97.26% (-0.64) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

